SCI时时刷

search
+
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment
Kidney involvement in systemic lupus erythematosus (SLE), known as lupus nephritis (LN), may be found in up to 60 % of pat...
Reframing health disparities in SLE: A critical reassessment of racial and ethnic differences in lupus disease outcomes
Reframing health disparities in SLE: A critical reassessment of racial and ethnic differences in lupus disease outcomes
Health disparities in the prevalence and outcomes of systemic lupus erythematosus (SLE) are well documented across racial ...
Assessment of disease activity and damage in SLE: Are we there yet?
Assessment of disease activity and damage in SLE: Are we there yet?
Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease with highly heterogeneous clinical presentation and co...
Structural disease modification in axial spondyloarthritis
Structural disease modification in axial spondyloarthritis
The concept of disease modification refers to interventions that affect the underlying pathophysiology of the disease, alt...
Pathophysiology and immunolgical basis of axial spondyloarthritis
Pathophysiology and immunolgical basis of axial spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic immune mediated inflammatory disease, characterized by inflammation and struc...
Systemic lupus erythematosus and damage: What has changed over the past 20 years?
Systemic lupus erythematosus and damage: What has changed over the past 20 years?
Systemic lupus erythematosus (SLE) is an autoimmune disorder that can affect many organ systems and all age groups in both...
Impact of sex and gender on axSpA diagnosis and outcomes
Impact of sex and gender on axSpA diagnosis and outcomes
Available online 25 November 2023, 101875Author links open overlay panel, , , , , , , AbstractAxial spondyloarthritis (axS...
Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future
Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future
Available online 19 November 2023, 101872Author links open overlay panelSection snippetsBurdenThe worldwide impact of OA i...
Management of systemic lupus erythematosus: A new scenario
Management of systemic lupus erythematosus: A new scenario
Systemic Lupus Erythematosus (SLE) is a complex, multifaceted disease that poses significant challenges with regards to di...
Advances in axial spondyloarthritis: Learning from the leaders
Advances in axial spondyloarthritis: Learning from the leaders
Available online 18 November 2023, 101877Author links open overlay panelSofia Ramiro, Nigil HaroonShow moreSection snippet...
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?
MdH: Consulting and speakers fees UCB.TD: Research support from Canon MS, ASAS; Consulting fees from Lilly, Speaker fees f...
Clash of the titans: Current CT and CT-like imaging modalities in sacroiliitis in spondyloarthritis
Clash of the titans: Current CT and CT-like imaging modalities in sacroiliitis in spondyloarthritis
Axial spondyloarthritis (axSpa) is a chronic inflammatory disease mainly targeting the axial skeleton, i.e. the spine and ...
Systemic lupus erythematosus and glucocorticoids: A never-ending story?
Systemic lupus erythematosus and glucocorticoids: A never-ending story?
Systemic lupus erythematosus (SLE) is a complex autoimmune disease, characterized by a wide spectrum of clinical manifesta...
Relapsing polychondritis: Best Practice & Clinical Rheumatology
Relapsing polychondritis: Best Practice & Clinical Rheumatology
Relapsing polychondritis (RP) is a rare systemic inflammatory disease that primarily affects cartilaginous structures in t...
Challenges in the diagnosis of axial spondyloarthritis
Challenges in the diagnosis of axial spondyloarthritis
Available online 14 September 2023, 101871Author links open overlay panel, AbstractWith back pain as one of the most commo...
Treatment overview of axial spondyloarthritis in 2023
Treatment overview of axial spondyloarthritis in 2023
Dr. Baraliakos: Research Support: Abbvie, Novartis, and MSD; Consultant, Speakers Bureau, Scientific Advisory Board and Ho...
The role of imaging in osteoarthritis
The role of imaging in osteoarthritis
Osteoarthritis (OA) is a prevalent and debilitating disease that affects a large population worldwide. With an estimated 2...
Diagnostic delay in axial spondylarthritis: A lost battle?
Diagnostic delay in axial spondylarthritis: A lost battle?
Diagnostic delay in axial spondylarthritis (axSpA) remains an unacceptable worldwide problem; with evidence suggesting sig...
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question
Spondyloarthritis (SpA) is a versatile group of chronic inflammatory rheumatic disorders that typically manifest in axial ...
Pregnancy & neonatal outcomes in spondyloarthritis
Pregnancy & neonatal outcomes in spondyloarthritis
Available online 29 August 2023, 101868Author links open overlay panel, AbstractLimited research has been conducted on the...
VEXAS syndrome, a new kid on the block of auto-inflammatory diseases: A hematologist's point of view
VEXAS syndrome, a new kid on the block of auto-inflammatory diseases: A hematologist's point of view
The recently discovered VEXAS syndrome (Vacuoles in myeloid progenitors, E1 ubiquitin ligase, X-linked, Auto-inflammatory ...
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting multiple organ systems. Several steps forward...
New and future therapies: Changes in the therapeutic armamentarium for SLE
New and future therapies: Changes in the therapeutic armamentarium for SLE
Following better understanding of molecular pathways involved in the pathogenesis of Systemic lupus erythematosus (SLE), p...
The burden of osteoarthritis: Is it a rising problem?
The burden of osteoarthritis: Is it a rising problem?
Osteoarthritis (OA) is the most common form of arthritis in the world [1]. The disease causes cartilage damage within a jo...
Musculoskeletal manifestations of systemic lupus erythematosus
Musculoskeletal manifestations of systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect multiple organ systems. Musculoskeletal...
Biomarkers for osteoarthritis: Current status and future prospects
Biomarkers for osteoarthritis: Current status and future prospects
Osteoarthritis (OA) is the most common form of arthritis globally and a major cause of pain, physical disability, and loss...
Vasculitis in the 21st century: From prayers to progress
Vasculitis in the 21st century: From prayers to progress
Obstetric complications are more common in women with systemic lupus erythematosus (SLE) than in the general population.To...
Peripheral spondyloarthritis: What have we learned?
Peripheral spondyloarthritis: What have we learned?
Breakthrough improvement in the understanding of spondyloarthritis (SpA) has been witnessed in the past couple of decades,...
Pregnancy in systemic lupus erythematosus
Pregnancy in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of clinical manifestations and a rela...
Vasculitis in the 20th century: From prayers to progress
Vasculitis in the 20th century: From prayers to progress
J.C. Jennette et al.Revised international chapel hill consensus conference nomenclature of vasculitidesArthritis Rheum(201...
阅读更多
format_indent_increase